Zahid Ali,Kenneth John Butcher,Richard Philip Butt,Stephen John Felstead,Sophie Glatt,Ruth Mitchell McKernan,Maninder Panesar
申请号：
US14351649
公开号：
US20140248252A1
申请日:
2012.10.19
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention is directed to 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide or a pharmaceutically acceptable salt thereof for the treatment of a disease associated with elevated blood uric acid levels, such as hyperuricemia or gout. The invention is also directed to the tosylate salt of 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide.
